Guardant Health

Ticker: GH

Sector: Health Care Providers & Services

Guardant Health

Guardant Health Inc. is a member of the Zacks.com (Strong Buy) list of Zacks. The consensus EPS estimate for the quarter has been revised 1.3%. Guardant Health ( NASDAQ:GH – Get Free Report ) last announced its quarterly earnings data on Thursday, August 3rd. Guardant health had a negative return on equity of 427.89% and a negative net margin of 99.62% Guardant has a Bullish sentiment reading. Guardant Healthcare Inc has gained 4.83% while the S&P 500 has fallen -0.12% on the stock sell has FinerawdownloadRocket Blu DUPbangLearnemis � incons Guardant Health ( NASDAQ:GH – Get Free Report ) last posted its earnings results on Thursday, August 3rd. There are 117.69 M shares outstanding in Guardant Health Inc Registered Shs, which values the company at $3.45 B. Compared to the closing price on Tuesday 10/03/2023 on NAS of $28.79, this is a drop of 0.00%. The high in the last 52 weeks of Guardant health stock was 62.63. Guardant Health has a market cap of $3.31 billion. As of October 2023 the market cap is the worlds 3066th most valuable company by market cap according to our data. Guardant is the 30th most valued company in the world. Guardant Health stock climbs following piper sandler sandler upgrade (gh) Share of Guardant shares were up 7% in afternoon trading following an upgrade by Piper Sandler. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics. Guardant has commercially launched Guardant360®, Guardant 360 CDx, and GuardantINFINITY™ tests for advanced-stage cancer patients, and  Guardant Reveal™ for early-stage. Guardant Health is a leading precision medicine company focused on helping conquer cancer globally. The Guardant health screening portfolio aims to address the needs of individuals eligible for cancer screening. Reimbursement Specialist, Payment Posting (Hybrid, Onsite or Remote Options) Reimbundation Specialist, Client Services (Regional Supervisor) Guardant Health   Stanford, CA Full Time Job Description We are looking for a full-time Client Services Supervisor. Guardant Health CEO Helmy Eltoukhy: CancerMoonshot dream for colorectal cancer is for all patients to have access to life-saving technologies like blood-based screening that can help identify cancers at their earliest stages Guardant Health hosted the WRP4LC at its headquarters to observe Lung Cancer Awareness Month. Guardant Health announces collaboration with Amgen to develop cancer-precision-oncology platform. The potential to target KRAS G12C represents a potentially major therapeutic advancement. Guardant Health CEO Helmy Eltoukhy: By 2030, #ColorectalCancer is projected to be the No. 1 cancer. GuardantINFINITY is a smart liquid biopsy that allows researchers to gain unprecedented insights.